Traditional treatment options for OSA include CPAP machines, custom dental devices, and the surgically implanted Inspire device. However, a new FDA-approved treatment called Zepbound (Tirzepatide) offers an innovative approach for those with moderate to severe sleep apnea.
Sleep apnea, a familiar yet often undiagnosed sleep disorder, has been increasingly recognized as a risk for heart disease. One of the characteristics of this condition is pauses in breathing during sleep, which affects your rest quality and poses a threat to cardiovascular health.
According to the American Thoracic Society, an estimated 1.5 million adults in the United States use supplemental oxygen to live longer and improve their quality of life. Many oxygen users are unfamiliar with the steps to travel with oxygen.